...
clym-img

Climb Bio Inc, Common Stock

CLYM

NMQ

$2.6

-$0.22

(-7.8%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$0
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
137.28K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.52 L
$11.55 H
$2.6

About Climb Bio Inc, Common Stock

Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware. more

Returns

Data is not properly formatted.

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses11.77M35.67M45.13M40.27M[{"date":"2020-12-31","value":26.07,"profit":true},{"date":"2021-12-31","value":79.03,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.23,"profit":true}]
Operating Income(11.77M)(35.67M)(45.13M)(40.27M)[{"date":"2020-12-31","value":-1176700000,"profit":false},{"date":"2021-12-31","value":-3567200000,"profit":false},{"date":"2022-12-31","value":-4513500000,"profit":false},{"date":"2023-12-31","value":-4027500000,"profit":false}]
Total Non-Operating Income/Expense--(109.00K)5.16M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-2.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(20.67M)(47.48M)(45.24M)(35.12M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}]
Income Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(20.67M)(47.48M)(45.24M)(35.12M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.67M)(47.48M)(45.24M)(35.12M)[{"date":"2020-12-31","value":-2066800000,"profit":false},{"date":"2021-12-31","value":-4748000000,"profit":false},{"date":"2022-12-31","value":-4524400000,"profit":false},{"date":"2023-12-31","value":-3511900000,"profit":false}]
EPS (Diluted)-(1.23)(1.71)(1.31)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-122.85,"profit":false},{"date":"2022-12-31","value":-171.4,"profit":false},{"date":"2023-12-31","value":-131.39,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CLYM
Current Ratio 60.41

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLYM
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLYM
Debt Ratio Lower is generally better. Negative is bad. 0.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.98

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLYM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Climb Bio Inc share price today?

Climb Bio Inc (CLYM) share price today is $2.6

Can Indians buy Climb Bio Inc shares?

Yes, Indians can buy shares of Climb Bio Inc (CLYM) on Vested. To buy Climb Bio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLYM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Climb Bio Inc be purchased?

Yes, you can purchase fractional shares of Climb Bio Inc (CLYM) via the Vested app. You can start investing in Climb Bio Inc (CLYM) with a minimum investment of $1.

How to invest in Climb Bio Inc shares from India?

You can invest in shares of Climb Bio Inc (CLYM) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLYM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Climb Bio Inc shares
What is Climb Bio Inc 52-week high and low stock price?

The 52-week high price of Climb Bio Inc (CLYM) is $11.55. The 52-week low price of Climb Bio Inc (CLYM) is $2.52.

What is Climb Bio Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Climb Bio Inc (CLYM) is

What is Climb Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Climb Bio Inc (CLYM) is 0.00

What is Climb Bio Inc dividend yield?

The dividend yield of Climb Bio Inc (CLYM) is 0.00%

What is the Market Cap of Climb Bio Inc?

The market capitalization of Climb Bio Inc (CLYM) is

What is Climb Bio Inc’s stock symbol?

The stock symbol (or ticker) of Climb Bio Inc is CLYM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top